ArticleSignal transduction and targeted therapy2023

Incorporation of a Toll-like receptor 2/6 agonist potentiates mRNA vaccines against cancer and infectious diseases.

Yangzhuo Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.